Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells 604 Shares of Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 604 shares of the business’s stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $26.98, for a total transaction of $16,295.92. Following the completion of the transaction, the senior vice president now directly owns 115,029 shares in the company, valued at $3,103,482.42. This trade represents a 0.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Amy Beth Vanduyn also recently made the following trade(s):

• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Trading Up 1.6 %

Shares of PHR stock opened at $27.24 on Friday. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The business’s fifty day moving average is $23.54 and its 200 day moving average is $22.81. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.58) EPS. Equities research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

PHR has been the subject of a number of recent research reports. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $31.00.

Hedge Funds Weigh In On Phreesia

Institutional investors have recently made changes to their positions in the stock. Trust Point Inc. lifted its holdings in shares of Phreesia by 3.5% during the 3rd quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after acquiring an additional 607 shares during the last quarter. Ensign Peak Advisors Inc boosted its holdings in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after purchasing an additional 700 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after purchasing an additional 853 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Phreesia by 3.3% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock valued at $637,000 after purchasing an additional 905 shares during the last quarter. Finally, MetLife Investment Management LLC raised its holdings in shares of Phreesia by 3.8% during the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock valued at $701,000 after buying an additional 1,120 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.